Marta Zuvic-Butorac

Marta Zuvic-Butorac

Auto-generated profile, based on publicly available information

Marta Zuvic-Butorac

University of Rijeka, Croatia

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2018 in Foods
Verified
Journal Article
Open access
PDF file
Jasminka GiacomettiJasminka Giacometti
Jasminka Giacometti
GŽGordana Žauhar
Gordana Žauhar
MŽMarta Žuvić
Marta Žuvić
The ultrasound-assisted extraction (UAE) of oleuropein (OLE), verbascoside (VER), and luteolin-4′-O-glucoside (L4OG), as the major phenolics from olive leaves, was optimized using response surface methodology (RSM). A Box–Behnken design (BBD) was used to monitor the effect of different modes of ultrasound operation (pulsed and continuous), liquid–solid (L–S) ratio, and sonication time on each phenolic yield. The yield of UAE and conventional solid extraction (CSE) was determined after performing ultrahigh-performance liquid chromatography with a diode-array detector (UHPLC-DAD) analysis on the extracts. The results suggested that, under optimal conditions, the concentrations of OLE, VER, and L4OG were 13.386, 0.363, and 0.527 mg/g of dry powdered olive leaves (DPOL), respectively. Verification of experiments was carried out under the modified optimal conditions and the relative errors between the predicted and experimental values were dependent on the examined phenolic compound (OLE 8.63%, VER 11.3%, and L4OG 22.48%). In comparison with CSE, UAE improved the yields of OLE, VER, and L4OG (32.6%, 41.8%, and 47.5%, respectively, after 1 min) at a temperature of 60 °C, an L–S ratio of 15 (v/w), and in the continuous mode of UAE. We demonstrated that the UAE technique is an efficient method for enhancing yields of OLE, VER, and L4OG in olive-leaf extracts, while the chosen model was adequate to optimize the extraction of major phenolic compounds from olive leaves.

17 January 2002 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
PDF file
DTDubravka Tišlarić
Dubravka Tišlarić
BBBojana Brajenović-Milić
Bojana Brajenović-Milić
SRSmiljana Ristić
Smiljana Ristić
VLVišnja Latin
Višnja Latin
MŽMarta Žuvić-Butorac
Marta Žuvić-Butorac
MKMiljenko Kapović
Miljenko Kapović
Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of α-fetoprotein and free β-subunit of human chorionic gonadotropin (free β-hCG). Methods: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks’ gestation and resulted with a birth of healthy child. Smoking status of mothers and data concerning gravidity and parity were collected at the sampling date. Serum markers were measured between 13 and 22 gestational weeks, corrected for maternal weight, and converted to multiples of median (MoM) for unaffected pregnancy of the corresponding gestational age. Median MoM values for both markers were examined in relation to both: smoking habits and number of previous births. Results: Smokers had significantly decreased free β-hCG MoM values compared to nonsmokers (p < 0.001). The median levels showed a negative relationship with the number of previous births. The significance of a decreasing trend was proved, both in smokers (p < 0.001) and nonsmokers (p < 0.001). The median maternal serum α-fetoprotein MoM values did not show any significant dependence, neither with regard to smoking (p = 0.65) nor with regard to parity (p = 0.07). Conclusions: The recommendable adjustment of serum markers to smoking habits, especially concerning the free β-hCG levels, would be worthwhile. The evidence of the coexisting influence of parity on serum levels of free β-hCG, both in smokers and nonsmokers, should perhaps be a stimulus for reconsideration of which corrections the screening performance is dependent on.

25 May 1999 in European Biophysics Journal
Verified
Journal Article
Closed access
PDF file
MZMarta Zuvic-Butorac
Marta Zuvic-Butorac
PMPeter Müller
Peter Müller
TPThomas Günther Pomorski
Thomas Günther Pomorski
JLJeanette Libera
Jeanette Libera
AHA. Herrmann
A. Herrmann
MSMilan Schara
Milan Schara

1 October 2014 in Croatian Medical Journal
Verified
Journal Article
Open access
FAFelina Anić
Felina Anić
MŽMarta Žuvić-Butorac
Marta Žuvić-Butorac
DŠDavor Štimac
Davor Štimac
SNSrđan Novak
Srđan Novak
To determine the prevalence of American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) classification criteria among systemic lupus erythematosus (SLE) patients; to determine disease activity and severity; and to investigate the correlation of classification criteria with disease activity, and of disease activity and damage index with disease duration. We performed a cross-sectional study on 110 SLE patients from the Division of Rheumatology and Clinical Immunology, University Hospital Centre Rijeka, Croatia in the period from September to December 2013 and determined disease duration and the total number of ACR and SLICC classification criteria. Disease activity was assessed by Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) index and organ damage by Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index. The number of SLICC classification criteria met per patient was significantly higher than the number of ACR criteria (7 [IQR 6-8] vs 5 [IQR 4-6], P < 0.001). Moderate correlations were detected between the number of SLICC classification criteria and disease activity index, both in case of active (r=0.48, P=0.003) and inactive disease (r=0.43, P < 0.001). We neither found a correlation between the number of ACR criteria and disease activity nor between disease activity and disease duration. However, there was a good correlation between SLICC/ACR damage index and disease duration (r=0.63, P < 0.001). New SLICC classification criteria correlate with disease activity because they capture more manifestations also included in the SLEDAI index. Patients with longer disease duration had a larger damage index score.

3 November 2011 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
ADAndrea Dekanić
Andrea Dekanić
RDRenata Dobrila Dintinjana
Renata Dobrila Dintinjana
IBIvana Budisavljević
Ivana Budisavljević
SPSanja Pećanić
Sanja Pećanić
MBMarta Žuvić Butorac
Marta Žuvić Butorac
NJNives Jonjić
Nives Jonjić
Background: Prognostic and predictive significance of epidermal growth factor receptor (EGFR) in colorectal carcinomas (CRCs) is still controversial. The aim of the present study was to explore and correlate membrane and nuclear EGFR and cyclin-D1 protein expression with EGFR gene status of tumor cells.Methods: Immunohistochemical and FISH analysis was performed on 135 archival formalin fixed and paraffin embedded CRCs.Results: Strong membrane and strong nuclear EGFR staining was detected in 16% and 57% of cases, respectively, and strong cyclin-D1 expression in 57% samples. Gene EGFR amplification was identified in 5.9% and polysomy in 7.4% of cases, while 87% showed no EGFR gene changes. A statistically significant difference was only found between tumor grade and expression of membrane EGFR, while nuclear EGFR and cyclin-D1 expression was not associated with the clinicopathologic characteristics analyzed. Tumor cells displaying gene amplification and strong protein membrane EGFR expression overlapped, while EGFR gene status showed no correlation with nuclear EGFR and cyclin-D1. There was no association between membrane EGFR and cyclin-D1, whereas nuclear EGFR expression was strongly related to cyclin-D1 expression.Conclusions: Study results revealed heterogeneity among CRCs, which could have a predictive value by identifying biologically and probably clinically different subsets of tumors with the possibly diverse response to anti-EGFR therapies.

1 October 2010 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
Alen ProtićAlen Protić
Alen Protić
MHMladen Horvat
Mladen Horvat
HKHelga Komen-Usljebrka
Helga Komen-Usljebrka
VFVedran Frkovic
Vedran Frkovic
MZMarta Zuvic-Butorac
Marta Zuvic-Butorac
AŠAlan Šustić
Alan Šustić